Cargando…

Interleukin 28B Polymorphism as a Predictor of Sustained Virological Response to Sofosbuvir-Based Therapy for Hepatitis C Virus Patients

In various genome-wide correlation studies, interleukin (IL)28B gene polymorphism has been strongly correlated with both the therapeutic and spontaneous mediated clearance of hepatitis C virus (HCV). Therefore, this study aimed to evaluate the genotype and allele frequency distributions of IL28B (rs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaki, Seham Mahrous, Ahmed, Hanan Samir, Yousif, Monkez Motieh, Awad, Eman Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501239/ https://www.ncbi.nlm.nih.gov/pubmed/36136642 http://dx.doi.org/10.3390/tropicalmed7090230

Ejemplares similares

The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
por: Han, Sung Yong, et al.
Publicado: (2021)

Achieving the Sustained Virologic Response With a Short-Course Treatment of Sofosbuvir/Velpatasvir
por: Abi-Saleh, Simon P, et al.
Publicado: (2023)

Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin
por: Meissner, Eric G., et al.
Publicado: (2014)

Impact of Interleukin 28B Genotype on the Virological Responses in Chronic Hepatitis C Treatment
por: Aygen, Bilgehan, et al.
Publicado: (2014)

Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study
por: Mekky, Mohamed A, et al.
Publicado: (2019)

Rapid virological&End treatment response of patients treated with Sofosbuvir in Chronic Hepatitis C
por: Siddique, Muhammad Shoaib, et al.
Publicado: (2017)

Predictors of early and sustained virological response of viral hepatitis C
por: Ghenea, Alice Elena, et al.
Publicado: (2020)

Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients
por: Mohamed Abdelnajid, Doaa, et al.
Publicado: (2023)

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response
por: van Wezel, E M, et al.
Publicado: (2019)

Sustained Virologic Suppression After 4 Weeks of Ledipasvir/Sofosbuvir in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Co-Infection
por: Havens, Joshua P., et al.
Publicado: (2020)

Effect of Health Insurance on Hepatitis C Sustained Virologic Response Rates to Sofosbuvir-Based Treatment Regimens in a South Florida Community Hospital
por: Eckardt, Paula, et al.
Publicado: (2019)

Health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
por: Miyasaka, Akio, et al.
Publicado: (2021)

Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study
por: Sacco, Rodolfo, et al.
Publicado: (2020)

Interleukin-28B polymorphisms and hepatitis C virus clearance
por: Chayama, Kazuaki, et al.
Publicado: (2013)

Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C
por: Daneshvar, Mahtab, et al.
Publicado: (2016)

Hemochromatosis Gene Polymorphism as a Predictor of Sustained Virological Response to Antiviral Treatment in Egyptian Chronic Hepatitis C Patients
por: I Mehrez, Mai, et al.
Publicado: (2017)

The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian patients With Chronic Hepatitis C
por: Sporea, Ioan, et al.
Publicado: (2011)

The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis
por: Khairy, Marwa, et al.
Publicado: (2013)

IL28B SNP rs12979860 Is a Critical Predictor for On-Treatment and Sustained Virologic Response in Patients with Hepatitis C Virus Genotype-1 Infection
por: Lin, Chun-Yen, et al.
Publicado: (2011)

Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B
por: Li, Shiying, et al.
Publicado: (2011)

Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects
por: Abdo, Ayman A., et al.
Publicado: (2009)

Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2016)

Progress in Medical Virology Vol. 28
por: Sutton, R. N. P.
Publicado: (1982)

High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting
por: Han, Qunying, et al.
Publicado: (2019)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
por: Orr, Cody, et al.
Publicado: (2020)

Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir
por: Manabe, Takushi, et al.
Publicado: (2022)

Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral Response
por: Asahina, Yasuhiro, et al.
Publicado: (2013)

Predictors of Sustained Virologic Response after Discontinuation of Nucleos(t)ide Analog Treatment for Chronic Hepatitis B
por: Peng, Jie, et al.
Publicado: (2015)

Antiviral Regimen Complexity Index as an Independent Predictor of Sustained Virologic Response in Patients with Chronic Hepatitis C
por: Galán, Rocío Jiménez, et al.
Publicado: (2013)

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
por: Welzel, Tania M, et al.
Publicado: (2016)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019)

Effectiveness of 12 week ledipasvir/sofosbuvir and predictors of treatment failure in patients with hepatitis C
por: del Rio-Valencia, Juan Carlos, et al.
Publicado: (2019)

Correlation between interleukin-28 gene polymorphism with interleukin-28 cytokine levels and viral genotypes among HCV patients in Yazd, Iran
por: Moghimi, Mansour, et al.
Publicado: (2019)

Durability of Sustained Virologic Response in Chronic Hepatitis C
por: Uyanikoglu, Ahmet, et al.
Publicado: (2013)

Interleukin 28B Gene Polymorphism and Association with Chronic Hepatitis C Therapy Results in Latvia
por: Tolmane, Ieva, et al.
Publicado: (2012)

Role of Interleukin-28B Genetic Polymorphisms in Korean Patients with Hepatitis C Virus Infection
por: Kil, Ho, et al.
Publicado: (2014)

Association of Hepatitis C Virus Infection and Interleukin-28B Gene Polymorphism in Chinese Children
por: Wu, Rong-Rong, et al.
Publicado: (2014)

Erratum: Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
Publicado: (2016)

Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
por: Tada, Toshifumi, et al.
Publicado: (2020)

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q277br6pl76ah4jgkmkq1h3e17